James Vergis
James M. Vergis, Ph.D. is a Principal with Faegre Drinker Consulting and a member of the firm’s Life Sciences Consortium Management Team. He provides scientific and strategic consulting services to pharmaceutical and biotechnology organizations and leads collaborative initiatives across industry consortia, including the Enabling Technologies Consortium (ETC), Allotrope Foundation, ELSIE, and the IQ Consortium. Through his work with ETC, Jamie helps pharmaceutical companies identify shared technology gaps, develop consensus-based requirements, and establish partnerships with technology providers to accelerate the development and commercialization of innovative laboratory solutions. His work spans emerging analytical technologies, data standardization, artificial intelligence and machine learning applications, and collaborative technology evaluation programs designed to ensure new tools are fit for purpose for regulated pharmaceutical environments. This includes initiatives focused on advanced measurement technologies, data interoperability, and federated approaches to AI-enabled drug development. Prior to joining Faegre Drinker, James held scientific research positions in academia and government. He earned a B.S. in Biochemistry with a minor in Computer Science from SUNY Geneseo and a Ph.D. in Molecular Biophysics and Biochemistry from Yale University.